Document is current
Any future updates will be listed below
-
Authors
Settipane, Russell A.
Germain, Guillaume
Laliberté, Francois
Mahendran, Malena
Hilts, Annalise
Duh, Mei Sheng
Paczkowski, Rosirene
Burrows, Emmeline
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 23 August 2024
Accepted: 16 December 2024
First Online: 27 January 2025
Declarations
:
: Russell A. Settipane has received compensation from GSK for speaking, advisory board services, and serving as an independent contractor for clinical trial research. Guillaume Germain, Francois Laliberté, Malena Mahendran, Annalise Hilts, and Mei Sheng Duh are employees of Analysis Group, Inc., a consulting company that received research funds from GSK to conduct this study. Rosirene Paczkowski and Emmeline Burrows are employed by GSK and hold financial equities in GSK. ELLIPTA and DISKUS are owned by or licensed to the GSK Group of companies. Clinformatics is a trademark of OptumInsight, Inc.
: This study complied with all applicable laws regarding subject privacy. No direct subject contact or primary collection of individual human subject data occurred. Study results were in tabular form and aggregate analyses that omit subject identification; therefore informed consent and ethics committee or institutional review board approval are not required. Any publications and reports will not include subject identifiers. Furthermore, this study used de-identified data that complied with the requirements of the Health Insurance Portability and Accountability Act (HIPAA).
